Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wolff

Showing results (101-110 of 177) with videos related to

Pageof 18
Sort By:
Blood|November 10, 2005
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHDKathrin Rieger, Christoph Loddenkemper, Jochem Maul, et al.
Haematologica|March 28, 2024
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignanciesMarkus Perl, Konstantin Herfeld, Dennis C Harrer, et al.
Plos One|September 22, 2017
The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantationDaniela Weber, Katrin Frauenschläger, Sakhila Ghimire, et al.
Blood Advances|March 11, 2024
Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantationJulia Winkler, Hannes Tittlbach, Andrea Schneider, et al.
Frontiers in Immunology|January 11, 2021
Potential Novel Biomarkers in Chronic Graft-Versus-Host DiseaseRachel E Crossland, Francesca Perutelli, Katarzyna Bogunia-Kubik, et al.
Frontiers in Immunology|November 15, 2021
GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum AntibioticsSakhila Ghimire, Daniela Weber, Katrin Hippe, et al.
Haematologica|February 10, 2022
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicinSabine Kayser, Chiara Sartor, Marlise R Luskin, et al.
Frontiers in Immunology|June 19, 2023
Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?Máté Krausz, Noriko Mitsuiki, Valeria Falcone, et al.
Bone Marrow Transplantation|May 30, 2003
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)Nicolaus Kröger, Hermann Einsele, Daniel Wolff, et al.
Frontiers in Immunology|November 21, 2022
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?Máté Krausz, Noriko Mitsuiki, Valeria Falcone, et al.
Pageof 18

Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Blood|November 10, 2005
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHDKathrin Rieger, Christoph Loddenkemper, Jochem Maul, et al.
Haematologica|March 28, 2024
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignanciesMarkus Perl, Konstantin Herfeld, Dennis C Harrer, et al.
Plos One|September 22, 2017
The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantationDaniela Weber, Katrin Frauenschläger, Sakhila Ghimire, et al.
Blood Advances|March 11, 2024
Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantationJulia Winkler, Hannes Tittlbach, Andrea Schneider, et al.
Frontiers in Immunology|January 11, 2021
Potential Novel Biomarkers in Chronic Graft-Versus-Host DiseaseRachel E Crossland, Francesca Perutelli, Katarzyna Bogunia-Kubik, et al.
Frontiers in Immunology|November 15, 2021
GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum AntibioticsSakhila Ghimire, Daniela Weber, Katrin Hippe, et al.
Haematologica|February 10, 2022
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicinSabine Kayser, Chiara Sartor, Marlise R Luskin, et al.
Frontiers in Immunology|June 19, 2023
Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?Máté Krausz, Noriko Mitsuiki, Valeria Falcone, et al.
Bone Marrow Transplantation|May 30, 2003
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)Nicolaus Kröger, Hermann Einsele, Daniel Wolff, et al.
Frontiers in Immunology|November 21, 2022
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?Máté Krausz, Noriko Mitsuiki, Valeria Falcone, et al.
Pageof 18